2019-11-01ãã1ã¶æéã®è¨äºä¸è¦§
Stata15ããæ¨æºæ©è½ã§æ½å¨ã¯ã©ã¹åæãã§ããããã«ãªã£ã¦ããã ãã ãåºæ¬çãªæ©è½ãããªããããStataã®æ¨æºæ©è½ã®æ½å¨ã¯ã©ã¹åæã¯ç¾å¨ã®ã¨ããå®ç¨ã«èããããªããããã§ãé¢åãªä½æ¥ãå¿ è¦ã«ãªãããLanzaããä½æããStata LCA ãã©ã°ã¤ã³ã使ããâ¦
ããªã³ããªãã¯ã¹(ãã«ããªãã»ãã³)ã«ã¤ãã¦ä¸ã¤æ°ã¥ãã¦ããªãã£ããã¨ããããä¸è¨ã®è¨äºãèªãã§æ°ä»ããã www.mdmag.com æ§æ©è½é害ãä»ã®æãã¤è¬ã«æ¯ã¹ã¦ä½ãã¨ããè£è¶³è¨è¿°ã2018å¹´10æ22æ¥ã«FDAã«åçãããã¨ããè¨äºã§ããã ç 究 å ã«ãªã£ãç â¦
ããªã³ããªãã¯ã¹ã11æ27æ¥çºå£²ã¨ãããã¨ãªã®ã§ãããªã³ããªãã¯ã¹ã®ã¬ãã¥ã¼è«æãç°¡åã«ç´¹ä»ãã¦ããããé©å¿ã®å¤§ãã¤ç æ§é害以å¤ã«å ¨è¬æ§ä¸å®çã«ã使ç¨ããã¦ããã ããªã³ããªãã¯ã¹ã®ã¬ãã¥ã¼ã¯ãªãããããããã£ã¦ãé©åãªãã®ãé¸ã¶ã®ãé£ãããâ¦
ä»åã¯æ½å¨ã¯ã©ã¹åæã®BLRTã®ã¨ã³ããªã®ç©ã¿æ®ãã§ããã RandomLCAããã±ã¼ã¸ãç¨ããæ½å¨ã¯ã©ã¹åæã¨BLRT[R] å ã®ã¨ã³ããªã¼ã§ã¯ä¿®æ£å¤ãå¤æ´ããã°ãã¼ãã¹ãã©ããã®å復åæ°ã¯é£åãã¦å¤ããããã®ã§ã¯ï¼ã¨æ¸ãã¦ããããä¿®æ£å¤ã¯ï¼ã®ã¾ã¾ã§ãä¸è¬çâ¦
å æ¥ãæ½å¨ã¯ã©ã¹åæã®BLRTãè¦ããã«ãã¼ãã¹ãã©ãããèµ°ãããã¨ãããã¨æéãããã£ãã999åã«è¨å®ãã¦ãããã¨ã大ããªåå ã«ãªã£ã¦ããããRããã·ã³ã°ã«ã³ã¢å¦çããã¦ããã®ãåå ã§ã¯ãªããã¨èãã並åå¦çã«ã¤ãã¦æ¤è¨ãã¦ã¿ããMplusã§ããã°â¦
ç§ãã¡ã使ãæ £ãã¦ãããã¼ã¿(è¡ã«ã±ã¼ã¹ãåã«å¤æ°ã¨ããå½¢å¼ã®ãã®)ã使ã£ã¦Rã§ãã¼ãã¹ãã©ãã尤度æ¯æ¤å®(Bootstrapped Likelihood Ratio Test)ãè¨ç®ããæ¹æ³ã«ã¤ãã¦ã®ã¨ã³ããªã§ããã poLCAã«ã¯æ®å¿µãªããBLRTã®æ©è½ããªãã®ã§ãpoLCAã®predcellé¢â¦
Rã§æ½å¨ã¯ã©ã¹åæãããããã±ã¼ã¸ã¨ãã¦ã¯poLCAãæåã ããRandomLCAã§ãæ½å¨ã¯ã©ã¹åæãã§ããã poLCAã§ã¯ãã¼ãã¹ãã©ãã尤度æ¯æ¤å®(Bootstrapped Likelihood Ratio Test: BLRT)ãã§ããªãããRandomLCAã§ã¯ã§ãããããã cran.r-project.org Randoâ¦
Rã®poLCAããã±ã¼ã¸ã§æ½å¨ã¯ã©ã¹åæã®ã¨ã³ãããã¼ãè¨ç®ãã¦ã¿ããã ç¸å¯¾çã¨ã³ãããã¼ã¨çµ¶å¯¾çã¨ã³ãããã¼ ã¨ã³ãããã¼ã¨ããææ¨ã¯Mplusã¦ã¼ã¶ã¼ã«ã¨ã£ã¦ã¯ã馴æã¿ã®ãã®ã§ããã Mplusã§åºåãããã®ã¯æ£ç¢ºã«è¨ãã¨ãç¸å¯¾çã¨ã³ãããã¼(Relative â¦
åºç¤çãªæã ãã©ããããããåç»ã ã大å¦æ°å¦ããã¤ãºã®å®çã確ççµ±è¨ã
Rã§å ±å¤éãä¼´ã£ãæ½å¨ã¯ã©ã¹åæãè¡ã£ã¦ã¿ããã ããã±ã¼ã¸ã¯poLCAã使ãã poLCAããã±ã¼ã¸ãå©ç¨ããæ½å¨ã¯ã©ã¹åæã¯ä»¥åã«ã¨ã³ããªãã¦ããã Rã®poLCAããã±ã¼ã¸ã§æ½å¨ã¯ã©ã¹åæãè¡ã å ±å¤éã¨ã¯ä½ãã¨ããã®ã¯ã以åã«Mplusã§ã®æ¹æ³ãã¨ã³ããªãâ¦
Stataã§ã¯æ½å¨ã¯ã©ã¹åæã®å¿ç確çã®æ£ã°ã©ããæãããæ£ã°ã©ãã¨ããã®ã¯ä»ã¾ã§è¦ããã¨ããªãã£ããä¸è¦ãªæ°ãããªãã§ããªããã説æããã¨ãã«ããããããã®ãããããªãã 使ç¨ããã®ã¯marginsã¨marginsplotã§ããã説æã«ããã¨æ¡ä»¶ä»ãå¿ç確çã®â¦
Stataã§æ½å¨ã¯ã©ã¹åæãã§ããã®ã§ãã£ã¦ã¿ãã Stata15ããæ¨æºæ©è½ã§å©ç¨ã§ãããããã Lanzaãã®ãã©ã°ã¤ã³ã使ãã°Stata11ããå©ç¨å¯è½ã§ããã www.methodology.psu.edu Stataã®æ¨æºæ©è½ã ã¨æ©è½ã足ããªãããã«æãã®ã§ãLanzaãã®ããã±ã¼ã¸ãçµå±â¦
Hardinã¨Hilbeã®Stataæ¬ã«ãããã¤ã¸ã¢ã³ãã¸ã¹ãã£ãã¯å帰åæã®ç¶ããä»åã¯äºååå¸ã¨ãã¦ã³ã¼ã·ã¼åå¸ã使ãæ¹æ³ã«ã¤ãã¦ã§ããã ï¼åç®ã¨ã³ããªã¯ãã¡ã ï¼åç®ã¨ã³ããªã¯ãã¡ã Generalized Linear Models and Extensions: Fourth Editionä½è : Jameâ¦
Hardinã¨Hilbeã®Stataæ¬ã«ãããã¤ã¸ã¢ã³ãã¸ã¹ãã£ãã¯å帰åæã®ç¶ããååã®ã¨ã³ããªã¯ãã¡ã Generalized Linear Models and Extensions: Fourth Editionä½è : James W. Hardin,Joseph M. Hilbeåºç社/ã¡ã¼ã«ã¼: Stata Pressçºå£²æ¥: 2018/06/28ã¡ãã£ã¢:â¦
ãã¹ã¦ã®è¥è ãçããããæªæ¥ãââ家æã»æè²ã»ä»äºããã®æé¤ã«æãã¦ä½è : å®®æ¬ã¿ã¡ååºç社/ã¡ã¼ã«ã¼: 岩波æ¸åºçºå£²æ¥: 2015/09/18ã¡ãã£ã¢: åè¡æ¬ï¼ã½ããã«ãã¼ï¼ãã®ååãå«ãããã°ãè¦ã å®®æ¬å çã«è¬æ¼ä¼ã§ãä¼ããã¦é æ´ãããã¾ããã ãããã¨â¦
dramanavi.net ç±³CNBCã«ããã¨ãæ¨å¹´åº¦Netflixå å ¥è ã®1æ¥å¹³åè¦è´æéã¯50åãããããã¤ã³ãåºèº«ã®ããç·æ§ã¯ã1æ¥7æéãNetflixã®ä½åãè¦ç¶ããã¨ããçæ´»ãå年以ä¸ãç¶ããçµæãç¡ç é害ã身ä½çç²å´ãç¼ç²¾ç²å´ãªã©ã®çç¶ãåºã¦ãã¾ããã¤ã³ãã®ãã³â¦
ãã¡ãã®ã¨ã³ããªã§Stataã§è¡ã£ããã¨ãRã§ããã£ã¦ã¿ããã æç çã®è¨ç®ã¯prevalenceããã±ã¼ã¸ãç¨ããã prevalence.cbra.be prevalenceããã±ã¼ã¸ã¯ãã¤ãºçµ±è¨å¦ã®è¨ç®ã«JAGSã¨rjagsãå©ç¨ããã JAGSã使ã£ããã¨ããªãå ´åã«ã¯ãã¤ã³ã¹ãã¼ã«ãå¿ è¦ã§â¦